icer white paper affordable access to glp-1 obesity medications 2025 Big policy shift in medicine. Starting July 1, 2026, Medicare will launch a temporary “GLP-1 Bridge” program allowing eligible patients drugs like Zepbound and Wegovy for about $50/month. For icer white paper affordable access

Compounded drugs can be important for overcoming shortages or meeting unique patient needsbut compounders should not try to compound drugs in a way that circumvents FDAs approval process. The FDA claims the companies are mass marketing their GLP-1s as similar alternatives to FDA-approved drugs

Tell all your healthcare providers that you are taking Zepbound before you are scheduled to have surgery or other procedures

If you have a family history of thyroid cancer, you shouldnt take liraglutide

The one exception: Very rapid weight loss or extreme weight loss can temporarily throw your cycles off as your body adjusts

10.1007/s00204-024-03879-z 104 SieberP.SchferA.LieberherrR.CaimiS

GHK-Cu, short for Glycyl-L-Histidyl-L-Lysine Copper, is a naturally occurring copper peptide that has garnered significant attention in the realm of health and wellness